In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


PEOPLE - Helicos BioSciences makes appointment:

This article was originally published in Clinica

Executive Summary

Lifescience company Helicos BioSciences (Cambridge, Massachusetts) has announced interim appointments in response to the resignation of Louise Mawhinney, senior vice-president and CFO. President and COO Steve Lombardi will step in as principal financial officer, while Kevin Lafond, the firm's controller, will stand in as principal accounting officer. Ms Mawhinney has left the firm to pursue other interests. Helicos' proprietary genetic analysis technology is designed to be used across the diagnostics, research and drug discovery markets.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts